Your gift is 100% tax deductible.
Key Statistics for Uterine Sarcoma
Learn about key statistics for uterine sarcomas, including how common they are and who is most affected.
How common are uterine sarcomas?
Uterine sarcomas are rare and make up about 5% of all uterine cancers. The most common types of uterine sarcomas are leiomyosarcoma and endometrial stromal sarcoma (ESS).
Who gets uterine sarcomas?
Most uterine sarcomas happen in people over the age of 40. The average age at diagnosis is about 60 years old.
Black women tend to have uterine leiomyosarcomas twice as often as White women, but not other types of uterine sarcomas.
Visit the American Cancer Society’s Cancer Statistics Center for more key statistics.
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Boggess JF, Kilgore JE, Tran AQ. Chapter 85: Uterine Cancer. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer. 2003;98(1):176-186.
Hosh M, Antar S, Nazzal A, Warda M, Gibreel A, Refky B. Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database. Int J Gynecol Cancer. 2016;26(6):1098-1104.
Memarzadeh S, Berek J. Uterine sarcoma: Classification, epidemiology, clinical mainfestations, and diagnosis. UpToDate. 2026. Accessed at https://www.uptodate.com/contents/uterine-sarcoma-classification-epidemiology-clinical-manifestations-and-diagnosis on February 17, 2026.
Last Revised: June 9, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
